Oculus VisionTech (OVTZ) 10-K 21 Mar 22 2021 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 21, 2022	Jun. 30, 2021
Document Information [Line Items]
Entity Central Index Key	0001107280
Entity Registrant Name	OCULUS VISIONTECH INC.
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	000-29651
Entity Incorporation, State or Country Code	WY
Entity Tax Identification Number	06-1576391
Entity Address, Address Line One	#507, 837 West Hastings Street
Entity Address, City or Town	Vancouver
Entity Address, State or Province	BC
Entity Address, Postal Zip Code	V6C 3N6
City Area Code	604
Local Phone Number	685-1017
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 37,800,000
Entity Common Stock, Shares Outstanding		91,422,469
Auditor Name	Davidson & Company LLP
Auditor Location	Vancouver, BC. Canada
Auditor Firm ID	731

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
ASSETS
Cash and cash equivalents	$ 2,208,451	$ 490,190
Prepaid expenses and other current assets	37,832	6,082
Total Assets	2,246,283	496,272
Current Liabilities:
Accounts payable and accrued expenses	96,198	32,329
Accounts payable and accrued expenses - related parties	26,425	135,738
Total current liabilities	122,623	168,067
Stockholders' Equity:
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 91,422,569 and 86,522,569	46,850,710	43,788,464
Contribution surplus	998,477	284,793
Commitment to issue shares	414,128	414,128
Accumulated other comprehensive income	6,190	0
Accumulated deficit	(46,145,845)	(44,159,180)
Stockholders' equity	2,123,660	328,205
Total Liabilities and Stockholders' Equity	$ 2,246,283	$ 496,272

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares $ / shares in Thousands	Dec. 31, 2021	Dec. 31, 2020
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized (in shares)	250,000,000	250,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, no par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	91,422,569	86,522,569
Common stock, shares outstanding (in shares)	91,422,569	86,522,569

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Expenses:
Consulting	$ 24,021	$ 0
Research and development (Note 11)	818,269	254,281
Selling, general and administrative (Note 10)	430,691	266,567
Share-based compensation (Note 8)	713,684	284,793
Impairment of intangible assets (Note 6)	0	1,966,939
Total expenses	1,986,665	2,772,580
Loss from operations	(1,986,665)	(2,772,580)
Other income
Interest income	0	96
Nonoperating Income (Expense), Total	0	96
Net loss	(1,986,665)	(2,772,484)
Other comprehensive loss
Currency translation differences	(6,190)	0
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total	(6,190)	0
Total comprehensive loss	$ (1,992,855)	$ (2,772,484)
Net loss per share – basic and diluted (in dollars per share)	$ (0.02)	$ (0.04)
Weighted average number of common shares outstanding – basic and diluted (in shares)	89,968,723	75,356,815

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($)	Common Stock Including Additional Paid in Capital [Member]	Contribution Surplus [Member]	Commitment to Issue Shares [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2019	67,022,568
Balance at Dec. 31, 2019	$ 41,634,999	$ 0	$ 0	$ 0	$ (41,386,696)	$ 248,303
Sale of common stock (in shares)	7,000,001
Sale of common stock	$ 773,038	0	0	0	0	773,038
Shares issued for asset acquisition (in shares)	12,500,000
Shares issued for asset acquisition	$ 1,380,427	0	0	0	0	1,380,427
Contingent consideration	0	0	414,128	0	0	414,128
Share-based compensation	0	284,793	0	0	0	284,793
Net loss	$ 0	0	0	0	(2,772,484)	(2,772,484)
Currency translation differences						0
Balance (in shares) at Dec. 31, 2020	86,522,569
Balance at Dec. 31, 2020	$ 43,788,464	284,793	414,128	0	(44,159,180)	328,205
Sale of common stock (in shares)	4,900,000
Sale of common stock	$ 3,098,616	0	0	0	0	3,098,616
Share-based compensation	0	713,684	0	0	0	713,684
Net loss	0	0	0	0	(1,986,665)	(1,986,665)
Share issuance costs - cash	(36,370)	0	0	0	0	(36,370)
Currency translation differences	$ 0	0	0	6,190	0	6,190
Balance (in shares) at Dec. 31, 2021	91,422,569
Balance at Dec. 31, 2021	$ 46,850,710	$ 998,477	$ 414,128	$ 6,190	$ (46,145,845)	$ 2,123,660

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net loss	$ (1,986,665)	$ (2,772,484)
Add back non-cash share-based compensation	713,684	284,793
Impairment of intangible assets (Note 6)	0	1,966,939
Changes in operating assets and liabilities:
Decrease in prepaid expenses and other current assets	(32,230)	(4,815)
Decrease (increase) in accounts payable and accrued expenses	63,869	(259,655)
Decrease (increase) in accounts payable and accrued expenses due to related parties	(108,833)	5,753
Net cash used in operating activities	(1,350,175)	(779,469)
Cash flows from investing activities:
Cash acquired on asset acquisition	0	114,169
Net cash provided by investing activities	0	114,169
Cash flows from financing activities:
Proceeds from sale of common stock	3,098,616	773,038
Share issuance costs	(36,370)	0
Net cash provided by financing activities	3,062,246	773,038
Effect of foreign currency translation	6,190	0
Net increase in cash and cash equivalents	1,718,261	107,738
Cash and cash equivalents at beginning of year	490,190	382,452
Cash and cash equivalents at end of year	2,208,451	490,190
Supplemental disclosures of cash flow information:
Cash paid during the year for interest	0	0
Cash paid during the year for income taxes	0	0
Non-cash financing and investing activities
Common stock issued on acquisition of CTI	0	1,380,427
Intangible acquired on acquisition of CTI	$ 0	$ (1,966,939)
Warrants issued on acquisition of CTI (in shares)	0	414,128
Account payable acquired on acquisition of CTI	$ 0	$ 172,384

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Business	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. BASIS OF PRESENTATION AND BUSINESS The accompanying consolidated financial statements include the accounts of Oculus Visiontech Inc. (“Oculus”) and its wholly-owned subsidiary, ComplyTrust Inc. (“CTI”), formerly OCL Technologies Corp. (from the date of acquisition in 2020, 6 Oculus VisionTech, Inc. (the " Company December 31, 2021 two

Note 2 - Going Concern

Note 2 - Going Concern	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	2. GOING CONCERN The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. Management has forecasted the Company will have sufficient working capital to operate for the ensuing 12 December 31, 2021 December 31, 2020. December 31, 2021, not In December 2019, 19 January 2020, March 2020, 19 19 none

Note 3 - Summary of Significant

Note 3 - Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Significant Accounting Policies [Text Block]	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of consolidation These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 21, 2022, December 31, 2021. These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% The controlled entities are listed in the following table: Name of Subsidiary Country of Incorporation Ownership Interest at December 31, 2021 Ownership Interest at December 31, 2020 Principal Activity ComplyTrust Inc. US/Delaware 100 % 100 % Software Development Significant judgments, estimates and assumptions The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows. The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not Significant judgments ● the determination of functional currencies; and Cash and cash equivalents Cash equivalents include highly liquid investments with original maturities of twelve Impairment of long-lived assets and long-lived assets to be disposed of Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not Research and development Expenditure on research activities is recognized on the consolidated statement of loss and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2021, not Intangible asset Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset may Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may Income taxes The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not not Net loss per share Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may December 31, 2021 2020, 2020: 2020: Right of use asset The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method. Lease liability The lease liability is initially measured at the present value of the lease payments that are not Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero. Stock-based compensation The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant. Functional currency The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus VisionTech Inc. is the Canadian (“CAD” or “C”) dollar and the functional currency of ComplyTrust Inc. is the U.S. dollar. In accordance with ASC 830, Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not Recently adopted accounting pronouncements Accounting Standards Update No. 2019 12—Income 740 December 2019, January 1, 2021 no Recently issued accounting pronouncements Accounting Standards Update No. 2016 13 June 2016, Accounting Standards Update No. 2018 19 326, November 2018, 2018 19 2018 270, not 326 20. 842, These updates are effective beginning January 1, 2023, 2016 13 2018 19

Note 4 - Prepaid Expenses and O

Note 4 - Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Other Assets Disclosure [Text Block]	4. PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consist of the following: 2021 2020 Prepaid expenses $ 28,141 $ 1,030 Tax Receivable – Canadian GST 9,691 5,052 $ 37,832 $ 6,082

Note 5 - Accounts Payable and A

Note 5 - Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	5. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consist of the following: 2021 2020 Accounts payable $ 61,836 $ 16,670 Accrued fees and expenses 34,362 15,659 $ 96,198 $ 32,329

Note 6 - Acquisition of Complyt

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp.	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	6. ACQUISITION OF COMPLYTRUST INC. ( CTI ), formerly OCL TECHNOLOGIES CORP. During the year ended December 31, 2020, not 805 10. Purchase Price Issuance of 12,500,000 $ 1,380,427 Contingent consideration - warrants 414,128 Transaction costs 54,532 Total Purchase Price $ 1,849,087 Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five June 4, 2025. No 1 5 2 3 Purchase Price Allocation Cash $ 114,169 Accounts payable and due from related party (232,021 ) Intangible asset 1,966,939 Total Purchase Price $ 1,849,087 During the year ended December 31, 2020,

Note 7 - Common Stock

Note 7 - Common Stock	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	7. COMMON STOCK The Company has one no 500,000,000 December 31, 2021 2020, December 31, 2021, On June 5, 2020, five June 4, 2025 On June 5, 2020, On June 14, 2021, CAD$0.80 $3,920,000CAD $1.00CAD may $2.50CAD $45,500CAD

Note 8 - Stock Options

Note 8 - Stock Options	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	8. STOCK OPTIONS During the years ended December 31, 2021 2020, may During the year ended December 31, 2021, i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CAD January 29, 2024. $424,300CAD, 125%; 0.14%; Nil; $1.18CAD. 6 July 29, 2021. December 31, 2021, $285,557CAD ii) granted 375,000 stock options to consultants, exercisable into 375,000 shares at an exercise price of $0.80CAD June 10, 2024. $211,700CAD, 120.80%; 0.25%; Nil; $0.80CAD. 6 December 10, 2021. December 31, 2021, $101,058CAD iii) granted 590,000 stock options to consultants, exercisable into 590,000 shares at an exercise price of $0.60CAD October 14, 2024. $219,100CAD, 119.89%; 0.63%; Nil; $0.54CAD. 6 April 14, 2021. December 31, 2021, $42,819CAD During the year ended December 31, 2020, i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CAD July 21, 2023. $909,900CAD, 125%; 0.27%; Nil; $0.35CAD. 6 January 21, 2020. December 31, 2020, $369,597CAD December 31, 2021, $406,133CAD ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CAD December 21, 2023. $75,800CAD, 125%; 0.02%; Nil; $0.425CAD. 6 June 21, 2021. December 31, 2020, $1,899CAD December 31, 2021, $52,835CAD The changes in options are as follows: Number of options Weighted average exercise price Aggregate Intrinsic Value Options outstanding, December 31, 2019 - $ - $ - Granted 3,850,000 0.36 - Options outstanding, December 31, 2020 3,850,000 0.36 3,363,000 Granted 1,465,000 0.86 - Options outstanding, December 31, 2021 5,315,000 $ 0.49 $ 3,910,950 The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for the options that were in-the-money at December 31, 2021. Details of options outstanding as at December 31, 2021 Exercise price (CAD) Number of options outstanding Expiry date Number of options exercisable Remaining contractual life (years) $ 0.350 3,600,000 July 21, 2023 1,440,000 1.55 $ 0.450 250,000 December 21, 2023 100,000 1.97 $ 1.200 500,000 January 29, 2024 100,000 2.08 $ 0.800 375,000 June 10, 2024 75,000 2.44 $ 0.600 590,000 October 14, 2024 - 2.79 5,315,000 1,715,000

Note 9 - Warrants

Note 9 - Warrants	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Class of Warrant or Right [Text Block]	9. WARRANTS The changes in warrants are as follows: Number of warrants Weighted average exercise price Warrants outstanding, December 31, 2019 - $ - Granted 12,500,000 0.001 Warrants outstanding, December 31, 2020 12,500,000 0.001 Granted 4,900,000 1.00 Warrants outstanding, December 31, 2021 17,400,000 $ 0.28 Details of warrants outstanding as at December 31, 2021 Exercise price Number of warrants outstanding Expiry date Number of warrants exercisable Remaining contractual life (years) $ 1.00 (CAD) 4,900,000 April 19, 2023 4,900,000 1.30 $ 0.001 (1) 12,500,000 June 4, 2025 - 3.43 17,400,000 4,900,000 ( 1 No 1 5 2 3

Note 10 - Selling, General and

Note 10 - Selling, General and Administrative	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Selling, General and Administrative Disclosure [Text Block]	10. SELLING, GENERAL AND ADMINISTRATIVE The breakdown of selling, general and administrative for the year ended December 31, 2021 2020 2021 2020 Filing and regulatory fees $ 38,396 $ 21,036 Marketing 41,374 13,840 Professional fees 133,134 74,800 Rent 39,134 - Office and administration 178,653 156,891 $ 430,691 $ 266,567

Note 11 - Research and Developm

Note 11 - Research and Development	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	11. RESEARCH AND DEVELOPMENT The breakdown of research and development for the year ended December 31, 2021 2020 2021 2020 Project management $ 144,000 $ 84,000 Software development 585,953 159,568 Business development 60,533 10,713 Payroll 27,783 - $ 818,269 $ 254,281

Note 12 - Income Taxes

Note 12 - Income Taxes	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Income Tax Disclosure [Text Block]	12. INCOME TAXES A reconciliation of income taxes at statutory rates with the reported taxes is as follows: December 31, 2021 December 31, 2020 Loss before taxes for the year $ (1,986,665 ) $ (2,772,484 ) Expected income tax (recovery) $ (417,000 ) $ (582,000 ) Effect of change in tax rates (64,000 ) (16,000 ) Permanent differences 150,000 60,000 Adjustment to prior years provision 2,147,000 2,086,000 Change in unrecognized deductible temporary (1,816,000 ) (1,548,000 ) Total income taxes $ - $ - Current income tax $ - $ - Deferred tax recovery $ - $ - The significant components of the Company’s deferred tax assets that have not December 31, 2021 December 31, 2020 Non-capital losses $ 5,010,903 $ 5,037,600 $ 5,010,903 $ 5,037,600 Unrecognized deferred tax assets (5,010,903 ) (5,037,600 ) Net deferred tax assets $ - $ - The significant components of the Company’s temporary differences, unused tax credits and unused tax losses that have not 2021 Expiry Date Range 2020 Expiry Date Range Temporary Differences Non-capital losses available for future periods $ 23,473,000 2026 to 2041 $ 23,904,000 2026 to 2040 Canada $ 22,304,000 2026 to 2041 $ 23,646,000 2026 to 2040 USA $ 1,169,000 2026 to 2041 $ 258,000 2026 to 2040

Note 13 - Related Parties

Note 13 - Related Parties	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	13. RELATED PARTIES Related parties include the Board of Directors, officers, close family members and enterprises that are controlled by these individuals as well as certain persons performing similar functions. The Company defines its key management as the Board of Directors, Chief Executive Officer, President, and Chief Financial Officer. Remuneration of directors and key management personnel of the Company was as follows: Year ended December 31, 2021 2020 Selling general and administrative $ 124,972 $ 27,479 Share-based compensation to directors and officers 151,261 132,210 $ 276,233 $ 159,689 The Company for the years ended December 31, 2021 2020 2020 December 31, 2021 2020. December 31, 2021 2020.

Note 14 - Operating Leases

Note 14 - Operating Leases	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	14. OPERATING LEASES The Company has one third The lease at the Vancouver, Canada location is on a month-to-month basis with monthly rental payments of $3,950 (CND). For the years ended December 31, 2021 2020

Note 15 - Segmented Information

Note 15 - Segmented Information	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	15. SEGMENTED INFORMATION The Company currently operates in a single reportable operating segment. All of the Company’s assets and expenditures are located in the United States. Since the Company does not no

Note 16 - Subsequent Events

Note 16 - Subsequent Events	12 Months Ended
	Dec. 31, 2021
Notes to Financial Statements
Subsequent Events [Text Block]	16. SUBSEQUENT EVENTS Subsequent to December 31, 2021, $0.80CAD January 31, 2025.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Basis of consolidation These consolidated financial statements are presented in United States dollars and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). On March 21, 2022, December 31, 2021. These consolidated financial statements include the financial statements of the Company and the entities controlled by the Company. The financial statements of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Control is defined as the exposure, or rights, to variable returns from involvement with an investee and the ability to affect those returns through power over the investee. Power over an investee exists when an investor has existing rights that give it the ability to direct the activities that significantly affect the investee’s returns. This control is generally evidenced through owning more than 50% The controlled entities are listed in the following table: Name of Subsidiary Country of Incorporation Ownership Interest at December 31, 2021 Ownership Interest at December 31, 2020 Principal Activity ComplyTrust Inc. US/Delaware 100 % 100 % Software Development
Use of Estimates, Policy [Policy Text Block]	Significant judgments, estimates and assumptions The preparation of financial statements in accordance with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the period. These judgments, estimates and assumptions are regularly evaluated and are based on management’s experience and knowledge of the relevant facts and circumstances. While management believes the estimates to be reasonable, actual results could differ from those estimates and could impact future results of operations and cash flows. The areas which require significant judgment and estimates that management has made at the financial reporting date, that could result in a material change to the carrying amounts of assets and liabilities, in the event actual results differ from the assumptions made, relate to, but are not Significant judgments ● the determination of functional currencies; and
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents Cash equivalents include highly liquid investments with original maturities of twelve
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long-lived assets and long-lived assets to be disposed of Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
Research and Development Expense, Policy [Policy Text Block]	Research and development Expenditure on research activities is recognized on the consolidated statement of loss and comprehensive loss as incurred. Development expenditures are capitalized as part of the cost of the resulting intangible asset only if the expenditures can be measured reliably, the product or process is technically and commercially feasible, future economic benefits are probable, and the Company intends to and has sufficient resources to complete development and to use or sell the asset. Management determined that as at December 31, 2021, not
Goodwill and Intangible Assets, Policy [Policy Text Block]	Intangible asset Identifiable intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is valued at fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and any accumulated impairment losses. The useful lives of intangible assets are assessed as either finite or indefinite. Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment annually and whenever there is an indication that the intangible asset may Intangible assets with indefinite lives are measured at cost less any accumulated impairment losses. These intangible assets are tested for impairment on an annual basis and more frequently if there are indicators that intangible assets may
Income Tax, Policy [Policy Text Block]	Income taxes The Company accounts for income taxes under the asset and liability method. Current income taxes are the expected taxes payable or receivable on the taxable income or loss for the year, using tax rates enacted or substantively enacted at the reporting date, and any adjustment to taxes payable in respect of previous years. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under the asset and liability method, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not not
Earnings Per Share, Policy [Policy Text Block]	Net loss per share Basic loss per share is calculated using the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if securities or contracts that may December 31, 2021 2020, 2020: 2020:
Lessee, Leases [Policy Text Block]	Right of use asset The Company recognizes a right of use asset and a lease liability at the lease commencement date. The right of use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove or to restore the underlying asset or the site on which it is located, less any lease incentives received. The right of use assets are subsequently amortized from the commencement date to the earlier of the end of the useful life of the right of use asset or the end of the lease term using the straight line method. Lease liability The lease liability is initially measured at the present value of the lease payments that are not Lease payments included in the measurement of the lease liability comprise the following payments during the lease term: fixed payments (including in-substance fixed payments), and the exercise price under a purchase option that the Company is reasonably certain to exercise. The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising mainly if the Company changes its assessment of whether it will exercise a purchase, renewal or termination option, or if there is a revised in substance fixed lease payment. When the lease liability is remeasured in this way, a corresponding adjustment is made to the carrying amount of the right of use asset, or is recorded in profit or loss if the carrying amount of the right of use asset has been reduced to zero.
Share-based Payment Arrangement [Policy Text Block]	Stock-based compensation The Company follows the provisions of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Section 718 The fair value at grant date of all share-based payments is recognized as compensation expense over the period for which benefits of services are expected to be derived, with a corresponding credit to shareholders’ equity or accrued liabilities depending on whether they are equity-settled or cash-settled. The Company estimates the fair value of stock options granted using the Black-Scholes option pricing model and estimate the expected forfeiture rate at the date of grant.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Functional currency The Company’s consolidated financial statements are presented in U.S. dollars, which is the Company’s reporting currency. The functional currency of Oculus VisionTech Inc. is the Canadian (“CAD” or “C”) dollar and the functional currency of ComplyTrust Inc. is the U.S. dollar. In accordance with ASC 830, Foreign currency transactions are translated into the functional currency of the respective currency of the entity or division, using the exchange rates prevailing at the dates of the transactions (spot exchange rate). Foreign exchange gains and losses resulting from the settlement of such transactions and from the re-measurement of monetary items denominated in foreign currency at period-end exchange rates are recognized in profit or loss. Non-monetary items that are not
New Accounting Pronouncements, Policy [Policy Text Block]	Recently adopted accounting pronouncements Accounting Standards Update No. 2019 12—Income 740 December 2019, January 1, 2021 no Recently issued accounting pronouncements Accounting Standards Update No. 2016 13 June 2016, Accounting Standards Update No. 2018 19 326, November 2018, 2018 19 2018 270, not 326 20. 842, These updates are effective beginning January 1, 2023, 2016 13 2018 19

Note 3 - Summary of Significa_2

Note 3 - Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]	Name of Subsidiary Country of Incorporation Ownership Interest at December 31, 2021 Ownership Interest at December 31, 2020 Principal Activity ComplyTrust Inc. US/Delaware 100 % 100 % Software Development

Note 4 - Prepaid Expenses and_2

Note 4 - Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	2021 2020 Prepaid expenses $ 28,141 $ 1,030 Tax Receivable – Canadian GST 9,691 5,052 $ 37,832 $ 6,082

Note 5 - Accounts Payable and_2

Note 5 - Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	2021 2020 Accounts payable $ 61,836 $ 16,670 Accrued fees and expenses 34,362 15,659 $ 96,198 $ 32,329

Note 6 - Acquisition of Compl_2

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp. (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Purchase Price Issuance of 12,500,000 $ 1,380,427 Contingent consideration - warrants 414,128 Transaction costs 54,532 Total Purchase Price $ 1,849,087
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Purchase Price Allocation Cash $ 114,169 Accounts payable and due from related party (232,021 ) Intangible asset 1,966,939 Total Purchase Price $ 1,849,087

Note 8 - Stock Options (Tables)

Note 8 - Stock Options (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Number of options Weighted average exercise price Aggregate Intrinsic Value Options outstanding, December 31, 2019 - $ - $ - Granted 3,850,000 0.36 - Options outstanding, December 31, 2020 3,850,000 0.36 3,363,000 Granted 1,465,000 0.86 - Options outstanding, December 31, 2021 5,315,000 $ 0.49 $ 3,910,950
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]	Exercise price (CAD) Number of options outstanding Expiry date Number of options exercisable Remaining contractual life (years) $ 0.350 3,600,000 July 21, 2023 1,440,000 1.55 $ 0.450 250,000 December 21, 2023 100,000 1.97 $ 1.200 500,000 January 29, 2024 100,000 2.08 $ 0.800 375,000 June 10, 2024 75,000 2.44 $ 0.600 590,000 October 14, 2024 - 2.79 5,315,000 1,715,000

Note 9 - Warrants (Tables)

Note 9 - Warrants (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Warrants or Right [Table Text Block]	Number of warrants Weighted average exercise price Warrants outstanding, December 31, 2019 - $ - Granted 12,500,000 0.001 Warrants outstanding, December 31, 2020 12,500,000 0.001 Granted 4,900,000 1.00 Warrants outstanding, December 31, 2021 17,400,000 $ 0.28 Exercise price Number of warrants outstanding Expiry date Number of warrants exercisable Remaining contractual life (years) $ 1.00 (CAD) 4,900,000 April 19, 2023 4,900,000 1.30 $ 0.001 (1) 12,500,000 June 4, 2025 - 3.43 17,400,000 4,900,000

Note 10 - Selling, General an_2

Note 10 - Selling, General and Administrative (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Selling, General and Administrative Expenses [Table Text Block]	2021 2020 Filing and regulatory fees $ 38,396 $ 21,036 Marketing 41,374 13,840 Professional fees 133,134 74,800 Rent 39,134 - Office and administration 178,653 156,891 $ 430,691 $ 266,567

Note 11 - Research and Develo_2

Note 11 - Research and Development (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Research and Development Expenses [Table Text Block]	2021 2020 Project management $ 144,000 $ 84,000 Software development 585,953 159,568 Business development 60,533 10,713 Payroll 27,783 - $ 818,269 $ 254,281

Note 12 - Income Taxes (Tables)

Note 12 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	December 31, 2021 December 31, 2020 Loss before taxes for the year $ (1,986,665 ) $ (2,772,484 ) Expected income tax (recovery) $ (417,000 ) $ (582,000 ) Effect of change in tax rates (64,000 ) (16,000 ) Permanent differences 150,000 60,000 Adjustment to prior years provision 2,147,000 2,086,000 Change in unrecognized deductible temporary (1,816,000 ) (1,548,000 ) Total income taxes $ - $ - Current income tax $ - $ - Deferred tax recovery $ - $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 31, 2021 December 31, 2020 Non-capital losses $ 5,010,903 $ 5,037,600 $ 5,010,903 $ 5,037,600 Unrecognized deferred tax assets (5,010,903 ) (5,037,600 ) Net deferred tax assets $ - $ -
Summary of Operating Loss Carryforwards [Table Text Block]	2021 Expiry Date Range 2020 Expiry Date Range Temporary Differences Non-capital losses available for future periods $ 23,473,000 2026 to 2041 $ 23,904,000 2026 to 2040 Canada $ 22,304,000 2026 to 2041 $ 23,646,000 2026 to 2040 USA $ 1,169,000 2026 to 2041 $ 258,000 2026 to 2040

Note 13 - Related Parties (Tabl

Note 13 - Related Parties (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Tables
Schedule of Related Party Transactions [Table Text Block]	Year ended December 31, 2021 2020 Selling general and administrative $ 124,972 $ 27,479 Share-based compensation to directors and officers 151,261 132,210 $ 276,233 $ 159,689

Note 2 - Going Concern (Details

Note 2 - Going Concern (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net Income (Loss) Attributable to Parent, Total	$ (1,986,665)	$ (2,772,484)
Retained Earnings (Accumulated Deficit), Ending Balance	(46,145,845)	$ (44,159,180)
Working Capital (Deficit)	$ 2,123,660

Note 3 - Summary of Significa_3

Note 3 - Summary of Significant Accounting Policies (Details Textual) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	5,315,000	3,850,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	4,900,000	4,900,000

Note 3 - Summary of Significa_4

Note 3 - Summary of Significant Accounting Policies - Summary of Subsidiary (Details)	Dec. 31, 2021	Dec. 31, 2020
ComplyTrust Inc. [Member]
ComplyTrust Inc.	100.00%	100.00%

Note 4 - Prepaid Expenses and_3

Note 4 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Prepaid expenses	$ 28,141	$ 1,030
Tax Receivable – Canadian GST	9,691	5,052
Prepaid Expense and Other Assets, Current	$ 37,832	$ 6,082

Note 5 - Accounts Payable and_3

Note 5 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Accounts payable	$ 61,836	$ 16,670
Accrued fees and expenses	34,362	15,659
Accounts Payable and Accrued Liabilities, Current, Total	$ 96,198	$ 32,329

Note 6 - Acquisition of Compl_3

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp. (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jun. 05, 2020	Dec. 31, 2019
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	$ 0	$ 1,380,427
Warrants and Rights Outstanding	$ 414,128	$ 414,128
Class of Warrant or Right, Outstanding (in shares)	17,400,000	12,500,000		0
Impairment of Intangible Assets (Excluding Goodwill), Total	$ 0	$ 1,966,939
OCL Technologies Corp [Member]
Business Acquisition, Percentage of Voting Interests Acquired		100.00%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		12,500,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 1,380,427
Warrants and Rights Outstanding		414,128
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 414,128
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)		12,500,000	12,500,000
Warrants and Rights Outstanding		$ 414,128
Class of Warrant or Right, Outstanding (in shares)		12,500,000	12,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.001	$ 0.001
Warrants and Rights Outstanding, Term (Year)		5 years	5 years

Note 6 - Acquisition of Compl_4

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp. - Purchase Price (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Common stock issued on acquisition of CTI	$ 0	$ 1,380,427
OCL Technologies Corp [Member]
Common stock issued on acquisition of CTI		1,380,427
Transaction costs		54,532
Total Purchase Price		1,849,087
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]
Common stock issued on acquisition of CTI		$ 414,128

Note 6 - Acquisition of Compl_5

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp. - Purchase Price (Details) (Parentheticals)	12 Months Ended
	Dec. 31, 2020shares
OCL Technologies Corp [Member]
Shares issued (in shares)	12,500,000

Note 6 - Acquisition of Compl_6

Note 6 - Acquisition of Complytrust Inc. ("CTI"), Formerly OCL Technologies Corp. - Purchase Price Allocation (Details) - OCL Technologies Corp [Member]	Dec. 31, 2020USD ($)
Cash	$ 114,169
Accounts payable and due from related party	(232,021)
Intangible asset	1,966,939
Total Purchase Price	$ 1,849,087

Note 7 - Common Stock (Details

Note 7 - Common Stock (Details Textual)	Jun. 14, 2021USD ($)shares	Jun. 14, 2021CAD ($)$ / sharesshares	Jun. 05, 2020$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Jun. 05, 2020$ / sharesshares	Dec. 31, 2019shares
Common Stock, No Par Value (in dollars per share) | $ / shares				$ 0	$ 0
Common Stock, Shares Authorized (in shares)				500,000,000	500,000,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)				91,422,569	86,522,569
Common Stock, Shares Held in Escrow (in shares)				5,175,000
Class of Warrant or Right, Outstanding (in shares)				17,400,000	12,500,000		0
Payments of Stock Issuance Costs | $				$ 36,370	$ 0
Private Placement [Member]
Equity Offering, Number of Units Issued (in shares)	4,900,000	4,900,000
Equity Offering, Price Per Unit Issued (in CAD per share) | $ / shares		$ 0.80
Proceeds from Issuance or Sale of Equity, Total	$ 3,098,616	$ 3,920,000
Equity Offering, Number of Common Shares Per Unit (in shares)		1
Warrants Issued in Connection with Private Placement [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares		$ 1
Warrants and Rights Outstanding, Term (Year)		24 months
Equity Offering, Number of Warrants Per Unit (in shares)		1
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)		1
Class of Warrant of Right, Stock Price Trigger (in CAD per share) | $ / shares		$ 2.50
Class of Warrant or Right, Threshold Consecutive Trading Days	10	10
Payments of Stock Issuance Costs	$ 36,370	$ 45,500
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]
Class of Warrant or Right, Outstanding (in shares)			12,500,000		12,500,000	12,500,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)			12,500,000		12,500,000	12,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 0.001		$ 0.001
Warrants and Rights Outstanding, Term (Year)			5 years		5 years	5 years
OCL Technologies Corp [Member]
Stock Issued During Period, Shares, New Issues (in shares)			12,500,000
Shares Issued, Price Per Share (in CAD per share) | $ / shares						$ 0.15
Investors [Member]
Stock Issued During Period, Shares, New Issues (in shares)			7,000,001
Shares Issued, Price Per Share (in CAD per share) | $ / shares						$ 0.15
Employee and Directors [Member]
Stock Issued During Period, Shares, New Issues (in shares)			1,766,667

Note 8 - Stock Options (Details

Note 8 - Stock Options (Details Textual)	Jan. 29, 2021CAD ($)$ / sharesshares	Dec. 21, 2020CAD ($)$ / sharesshares	Jul. 21, 2020CAD ($)$ / sharesshares	Dec. 31, 2021USD ($)shares	Dec. 31, 2021CAD ($)$ / sharesshares	Dec. 31, 2020USD ($)shares	Dec. 31, 2020CAD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)				1,465,000	1,465,000	3,850,000	3,850,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)					1,715,000
Share-based Payment Arrangement, Expense | $				$ 713,684		$ 284,793
Rolling Stock Option Plan [Member]
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved					10.00%	10.00%	10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)		250,000	3,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)		250,000	3,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares		$ 0.45	$ 0.35
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $		$ 75,800	$ 909,900
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares	$ 1.20
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $	$ 424,300
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	125.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions	0.14%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%
Share-based Payment Arrangement, Expense				$ 230,215	$ 285,557
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of January 29, 2024 [Member] | Vesting Every Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares	$ 1.18
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	20.00%
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of June10, 2024 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)				375,000	375,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)					375,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares					$ 0.80
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $					$ 211,700
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				120.80%	120.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)				3 years	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions				0.25%	0.25%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares					$ 0.80
Share-based Payment Arrangement, Expense				$ 83,342	$ 101,058
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate		125.00%	125.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)		3 years	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions		0.02%	0.27%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares		$ 0.425	$ 0.35
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | July 2020 [Member]
Share-based Payment Arrangement, Expense				$ 324,132	$ 406,133		$ 369,597
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | December 2020 [Member]
Share-based Payment Arrangement, Expense | $							$ 1,899
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | Vesting Every Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				20.00%	20.00%
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		20.00%	20.00%
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of October 14, 2024 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)				590,000	590,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)					590,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares					$ 0.60
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $					$ 219,100
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				119.89%	119.89%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year)				3 years	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions				0.63%	0.63%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%	0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares					$ 0.54
Share-based Payment Arrangement, Expense				$ 33,964	$ 42,819
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of October 14, 2024 [Member] | Vesting Every Six Months [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				20.00%	20.00%
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of July 21, 2023 [Member]
Share-based Payment Arrangement, Expense | $						$ 283,307
Rolling Stock Option Plan [Member] | Employee Stock Option, Expiration Date of December 21, 2023 [Member]
Share-based Payment Arrangement, Expense				$ 42,031	$ 52,835	$ 1,486

Note 8 - Stock Options - Change

Note 8 - Stock Options - Changes in Options (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Options outstanding (in shares)	3,850,000	0
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.36	$ 0
Options outstanding, aggregate intrinsic value	$ 3,910,950	$ 3,363,000	$ 0
Granted, options (in shares)	1,465,000	3,850,000
Granted, weighted average exercise price (in dollars per share)	$ 0.86	$ 0.36
Granted, aggregate intrinsic value (in dollars per share)	$ 0	$ 0
Options outstanding (in shares)	5,315,000	3,850,000
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.49	$ 0.36

Note 8 - Stock Options - Detail

Note 8 - Stock Options - Details of Options Outstanding (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares	Dec. 31, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares
Exercise price (in CAD per share) | $ / shares	$ 0.49		$ 0.36	$ 0
Number of options outstanding (in shares)	5,315,000	5,315,000	3,850,000	0
Number of options exercisable (in shares)	1,715,000	1,715,000
Range One [Member]
Exercise price (in CAD per share) | $ / shares		$ 0.350
Number of options outstanding (in shares)	3,600,000	3,600,000
Number of options exercisable (in shares)	1,440,000	1,440,000
Remaining contractual life (Year)	1 year 6 months 18 days
Range Two [Member]
Exercise price (in CAD per share) | $ / shares		$ 0.450
Number of options outstanding (in shares)	250,000	250,000
Number of options exercisable (in shares)	100,000	100,000
Remaining contractual life (Year)	1 year 11 months 19 days
Range Three [Member]
Exercise price (in CAD per share) | $ / shares		$ 1.200
Number of options outstanding (in shares)	500,000	500,000
Number of options exercisable (in shares)	100,000	100,000
Remaining contractual life (Year)	2 years 29 days
Range Four [Member]
Exercise price (in CAD per share) | $ / shares		$ 0.800
Number of options outstanding (in shares)	375,000	375,000
Number of options exercisable (in shares)	75,000	75,000
Remaining contractual life (Year)	2 years 5 months 8 days
Range Five [Member]
Exercise price (in CAD per share) | $ / shares		$ 0.600
Number of options outstanding (in shares)	590,000	590,000
Number of options exercisable (in shares)	0	0
Remaining contractual life (Year)	2 years 9 months 14 days

Note 9 - Warrants - Schedule of

Note 9 - Warrants - Schedule of Warrants (Details)		12 Months Ended
		Dec. 31, 2021$ / shares$ / sharesshares	Dec. 31, 2020$ / sharesshares
Warrants outstanding (in shares)		12,500,000	0
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares		$ 0.001	$ 0
Granted, warrants (in shares)		4,900,000	12,500,000
Granted, weighted average exercise price (in dollars per share) | $ / shares		$ 1	$ 0.001
Warrants outstanding (in shares)		17,400,000	12,500,000
Warrants outstanding, weighted average exercise price (in dollars per share) | $ / shares		$ 0.28	$ 0.001
Number of warrants outstanding (in shares)		17,400,000	12,500,000
Number of warrants exercisable (in shares)		4,900,000
Warrants Expiring on April 19, 2023 [Member]
Warrants outstanding (in shares)		4,900,000
Exercise price (in CAD per share) | $ / shares		$ 1
Number of warrants outstanding (in shares)		4,900,000
Number of warrants exercisable (in shares)		4,900,000
Remaining contractual life (Year)		1 year 3 months 18 days
Warrants Expiring on June 4, 2025 [Member]
Warrants outstanding (in shares)	[1]	12,500,000
Number of warrants outstanding (in shares)	[1]	12,500,000
Number of warrants exercisable (in shares)	[1]	0
Remaining contractual life (Year)	[1]	3 years 5 months 4 days
[1]	No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per CTI’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control.

Note 10 - Selling, General an_3

Note 10 - Selling, General and Administrative - Selling, General and Administrative Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Filing and regulatory fees	$ 38,396	$ 21,036
Marketing	41,374	13,840
Professional fees	133,134	74,800
Rent	39,134	0
Office and administration	178,653	156,891
Selling, General and Administrative Expense, Total	$ 430,691	$ 266,567

Note 11 - Research and Develo_3

Note 11 - Research and Development - Research and Development (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Project management	$ 144,000	$ 84,000
Software development	585,953	159,568
Business development	60,533	10,713
Payroll	27,783	0
Research and Development Expense, Total	$ 818,269	$ 254,281

Note 12 - Income Taxes - Reconc

Note 12 - Income Taxes - Reconciliation of Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Loss before taxes for the year	$ (1,986,665)	$ (2,772,484)
Expected income tax (recovery)	(417,000)	(582,000)
Effect of change in tax rates	(64,000)	(16,000)
Permanent differences	150,000	60,000
Adjustment to prior years provision	2,147,000	2,086,000
Change in unrecognized deductible temporary	(1,816,000)	(1,548,000)
Total income taxes	0	0
Current income tax	0	0
Deferred tax recovery	$ 0	$ 0

Note 12 - Income Taxes - Net De

Note 12 - Income Taxes - Net Deferred Tax Assets (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Non-capital losses	$ 5,010,903	$ 5,037,600
Deferred Tax Assets, Gross, Total	5,010,903	5,037,600
Unrecognized deferred tax assets	(5,010,903)	(5,037,600)
Net deferred tax assets	$ 0	$ 0

Note 12 - Income Taxes - Compon

Note 12 - Income Taxes - Components of Temporary Difference (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operatinting loss	$ 23,473,000	$ 23,904,000
Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Operatinting loss	22,304,000	23,646,000
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Operatinting loss	$ 1,169,000	$ 258,000
Minimum [Member]
Expiry date	Dec. 31, 2026	Dec. 31, 2026
Minimum [Member] | Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Expiry date	Dec. 31, 2026	Dec. 31, 2026
Minimum [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Expiry date	Dec. 31, 2026	Dec. 31, 2026
Maximum [Member]
Expiry date	Dec. 31, 2041	Dec. 31, 2040
Maximum [Member] | Foreign Tax Authority [Member] | Canada Revenue Agency [Member]
Expiry date	Dec. 31, 2041	Dec. 31, 2040
Maximum [Member] | Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Expiry date	Dec. 31, 2041	Dec. 31, 2040

Note 13 - Related Parties (Deta

Note 13 - Related Parties (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction, Expenses from Transactions with Related Party	$ 276,233	$ 159,689
Share-based Compensation [Member]
Related Party Transaction, Expenses from Transactions with Related Party	151,261	132,210
Research and Development Expense [Member]
Related Party Transaction, Expenses from Transactions with Related Party	0	0
Reimbursement [Member]
Related Party Transaction, Amounts of Transaction	$ 124,972	$ 27,479

Note 13 - Related Parties - Rel

Note 13 - Related Parties - Related Party Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
related party expense	$ 276,233	$ 159,689
Selling, General and Administrative Expenses [Member]
related party expense	124,972	27,479
Share-based Compensation [Member]
related party expense	$ 151,261	$ 132,210

Note 14 - Operating Leases (Det

Note 14 - Operating Leases (Details Textual)	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2021CAD ($)	Dec. 31, 2020USD ($)
Operating Lease, Expense	$ 39,134		$ 0
Vancouver, CA Operating Lease [Member]
Operating Leases, Monthly Rent Expense		$ 3,950
Operating Lease, Expense	$ 36,340		$ 38,651

Note 16 - Subsequent Events (De

Note 16 - Subsequent Events (Details Textual) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 21, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)		1,465,000	3,850,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)		1,715,000
Option Expiring on January 31, 2025 [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares)	100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share)	$ 0.80